Suppr超能文献

基于伴侣的 HIV 预防方法在跨性别女性及其伴侣中的应用:一项随机对照试验研究方案,旨在测试“二人同心”干预措施的效果。

Couples-based approach to HIV prevention for transgender women and their partners: study protocol for a randomised controlled trial testing the efficacy of the 'It Takes Two' intervention.

机构信息

Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.

Center for AIDS Prevention Studies, University of California, San Francisco, California, USA.

出版信息

BMJ Open. 2020 Oct 15;10(10):e038723. doi: 10.1136/bmjopen-2020-038723.

Abstract

INTRODUCTION

HIV transmission and acquisition risk among transgender women is particularly high in the context of primary partnerships. This project extends a previous pilot couples-focused HIV intervention programme, which was shown to be feasible, acceptable and promising in reducing sexual risk behaviour among transgender women and their partners. This randomised controlled trial (RCT) tests the efficacy of this culturally sensitive HIV prevention programme for HIV-serodiscordant and HIV-negative seroconcordant transgender women and their partners.

METHODS AND ANALYSIS

To finalise the protocol for trial, we used qualitative methods to hone eligibility criteria, refine the intervention and control manuals, and name and brand the intervention ('It Takes Two'). The RCT investigates the effects of the It Takes Two intervention on Composite Risk for HIV (CR-HIV) among 100 couples. CR-HIV is a binary indicator of couple HIV risk using validated measures of sexual behaviour, pre-exposure prophylaxis use among HIV-negative participants and viral suppression among participants living with HIV. Using a two-arm RCT, we will examine intervention effects on CR-HIV at 12-month follow-up comparing transgender women and their partners randomised to the intervention versus control (HIV prevention information only).

ETHICS AND DISSEMINATION

This study has been reviewed and approved by the University of California, San Francisco (19-28624) and the University of Michigan (HUM00147690) Institutional Review Boards. Participants provide informed consent before taking part of the study activities. Results will be published in peer-reviewed journals and presented at scientific conferences. We will make our results available to the community of researchers and general public interested in transgender health to avoid unintentional duplication of research, as well as to others in the health and social services community, including LGBT community-based organisations, AIDS service organisations and other transgender-serving organisations. The full de-identified dataset and codebook will be shared at the University of Michigan Digital Repository.

TRIAL REGISTRATION NUMBER

NCT04067661.

摘要

介绍

在原发性伴侣关系中,跨性别女性的 HIV 传播和感染风险特别高。本项目扩展了之前一项针对伴侣的试点 HIV 干预项目,该项目已证明在减少跨性别女性及其伴侣的性风险行为方面是可行、可接受和有希望的。这项随机对照试验(RCT)测试了这种针对 HIV 血清不一致和 HIV 血清一致的跨性别女性及其伴侣的文化敏感 HIV 预防方案的疗效。

方法和分析

为了敲定试验方案,我们使用定性方法来完善资格标准、改进干预和对照手册,并为干预措施命名和品牌(“需要两个人”)。该 RCT 调查了“需要两个人”干预措施对 100 对夫妇的复合 HIV 风险(CR-HIV)的影响。CR-HIV 是使用经过验证的性行为测量、HIV 阴性参与者使用暴露前预防措施和 HIV 感染者病毒抑制的指标,用于衡量夫妻 HIV 风险的二元指标。本研究采用两臂 RCT,通过比较随机分配到干预组和对照组(仅 HIV 预防信息)的跨性别女性及其伴侣的 12 个月随访时的 CR-HIV,来检验干预效果。

伦理和传播

本研究已通过加利福尼亚大学旧金山分校(19-28624)和密歇根大学(HUM00147690)机构审查委员会的审查和批准。参与者在参与研究活动之前提供知情同意。研究结果将发表在同行评议的期刊上,并在科学会议上展示。我们将向对跨性别健康感兴趣的研究人员和公众社区以及包括 LGBT 社区组织、艾滋病服务组织和其他为跨性别者服务的组织在内的卫生和社会服务界的其他组织提供我们的研究结果,以避免无意重复研究。完整的去识别数据集和代码本将在密歇根大学数字资源库中共享。

试验注册号

NCT04067661。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1db6/7566735/3d92b70321e8/bmjopen-2020-038723f01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验